QDK — Integrated Continuous Glucose Monitoring System For Non-Intensive Diabetes Management Class II

FDA Device Classification

Classification Details

Product Code
QDK
Device Class
Class II
Regulation Number
862.1355
Submission Type
Review Panel
CH
Medical Specialty
Clinical Chemistry
Implant
No

Definition

An integrated continuous glucose monitoring system for non-intensive diabetes management is intended to replace finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes who do not have significant risk of severe hypoglycemia. The device also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating long-term therapy adjustments. The device is also intended to autonomously communicate with digitally connected devices. The device can be used alone or in conjunction with these digitally connected devices or services for the purpose of managing diabetes.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K203089dexcomDexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) SystemAugust 17, 2021
K193642dexcomDexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) SystemJanuary 29, 2020
K192787dexcomDexcom G6 Glucose Program Continuous Glucose Monitoring (GCM) SystemOctober 25, 2019
K182041dexcomDexcom G6 Glucose Program Continuous Glucose Monitoring SystemOctober 26, 2018